Fetal exposure, heredity and risk indicators for cardiovascular disease in a Swedish welfare cohort

I Mogren1, U Högberg, B Stegmayr

  • 1Department of Clinical Science, Obstetrics and Gynecology, Umeå University, S-90185 Umeå, Sweden.

Insights

Low birthweight (LBW) is linked to higher blood pressure and cholesterol levels in middle age. However, heredity plays a more significant role in elevated systolic blood pressure (SBP) than LBW.

Area of Science:

  • Cardiovascular Epidemiology
  • Developmental Origins of Health and Disease (DOHaD)

Background:

  • Investigating the association between low birthweight (LBW) and cardiovascular disease (CVD) risk factors in middle age within a welfare society.
  • Examining potential interactions between LBW and genetic predisposition for myocardial infarction or stroke.

Purpose of the Study:

  • To determine if LBW in newborns is associated with CVD risk indicators in early middle age.
  • To explore the interplay between LBW and heredity on cardiovascular risk markers.

Main Methods:

  • Longitudinal study identifying subjects from a birth register and the Västerbotten Intervention Program (n=7876).
  • Assessed outcomes including systolic blood pressure (SBP), diastolic blood pressure (DBP), body mass index (BMI), cholesterol, and triglycerides at ages 29-41.
  • Analyzed outcomes in relation to birthweight status.

Main Results:

  • LBW was associated with increased SBP and DBP.
  • Elevated triglycerides were observed in women with LBW, and elevated total cholesterol in men with LBW.
  • A synergistic effect between LBW and heredity was noted for SBP levels; BMI did not differ significantly.

Conclusions:

  • The 'fetal origins' hypothesis is supported for middle-aged individuals in a welfare society.
  • While LBW has associations, heredity is a more significant public health factor for elevated SBP.
  • Population attributable risks from LBW exposure were relatively small.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...